NextFin news, Touchstone Investments released the Q3 2025 portfolio review for the Touchstone Mid Cap Fund (Class A Shares, Load Waived) on November 24, 2025, outlining the Fund's performance relative to its benchmark, the Russell MidCap® Index. The analysis period covers the quarter ended September 30, 2025, and provides insights into stock selection, sector exposures, and factor impacts shaping the Fund’s returns.
The Fund underperformed its benchmark during the quarter, primarily attributed to both stock picking and sector allocation decisions. While the Fund maintained an overweight position in Industrials, which posted relatively stronger returns, it was offset by overweight exposure to Consumer Staples—the weakest performing sector—and an underweight allocation to Communication Services, a better-performing sector. These sector tilts, combined with the portfolio’s emphasis on quality factors, translated into a relative performance headwind amid heightened volatility.
Quality factors, the cornerstone of the Fund’s investment philosophy favoring companies with durable competitive advantages, strong balance sheets, and steady free cash flow, transitioned from a tailwind earlier in the year to a headwind in Q3 2025. This shift was driven by a surge in market volatility where investors favored more speculative, low-quality and negative-earnings stocks on hopes of Federal Reserve rate cuts. Such a trend aligns with historical behavioral patterns following recessions or policy shifts where market participants prioritize speed and speculation over stability.
Top contributors to the Fund’s Q3 performance included Somnigroup International, an industrial consumer discretionary company gaining market share despite end-market softness and benefiting from an accelerated integration with Mattress Firm. Armstrong World Industries, a leader in industrial building products, outperformed by beating earnings expectations with strong operating leverage and exclusivity agreements enhancing its moat. NewMarket Corporation, operating in the materials sector, saw improved profitability due to lower input costs driven by oil price declines, strategic defense acquisitions amidst global conflicts, and prudent debt reduction strategies funded by cash flow.
Conversely, Fidelity National Information Services (FIS) faced underperformance due to uneven execution and a cautious outlook requiring accelerated improvements later in the year. Allison Transmission Holdings suffered from trade policy uncertainty impacting North American demand, while AptarGroup experienced challenges from a prolonged recovery in its Consumer Healthcare division and intensified competition despite overall growth across its pharma, beauty, and closures businesses.
Notable portfolio changes included initiating a new position in Avantor, Inc., a healthcare sector company specializing in mission-critical biopharma and life sciences products with high recurring revenue (~85%) and substantial switching costs, positioning it well to benefit from secular trends like biologics expansion and personalized medicine. Simultaneously, the Fund trimmed its holdings in Amphenol Corporation due to its considerable market cap growth (~$150 billion), reflecting a strategic reduction after strong multi-year performance.
From an analytical perspective, the Fund’s Q3 2025 performance underscores the cyclical tension between quality and speculative investment styles within mid-cap equities. The underperformance amid surging volatility and investor rotation toward lower-quality equities suggests a market environment sensitive to Federal Reserve policy signals and economic growth prospects under the current U.S. administration led by President Donald Trump. The Fund’s overweight in Industrials and underweight in Real Estate helped mitigate some losses yet demonstrated the complexity of effective sector rotation in this volatile regime.
Given these dynamics, the Fund's commitment to high-quality, low-volatility stocks can be viewed as a defensive posture that may underperform during rapid risk-on cycles but provides resilience during downturns and market uncertainty. The headwinds experienced are consistent with historical patterns where post-recession markets reward agility and speculative bets before reverting to fundamentals. The Fund’s investment in companies with robust free cash flow generation, market share advantages, and strong balance sheets is expected to provide a durable foundation for long-term capital appreciation once volatility stabilizes and monetary policy clarity improves.
The inclusion of Avantor reflects a strategic adaptation to align with growth in the life sciences sector, which benefits from structural trends such as increased biopharmaceutical R&D spending, the rise of personalized medicine, and global healthcare innovations. This shift highlights a proactive approach to portfolio diversification within mid caps, targeting secular growth themes despite cyclical headwinds.
Looking ahead, investors should monitor the evolving landscape of Fed policies, geopolitical risks impacting industrial and materials sectors, and sector leadership transitions as mid-cap stocks navigate a complex macroeconomic environment. The Fund’s strategy of emphasizing quality and stable cash flows amidst this backdrop positions it to capitalize on the eventual cyclical recovery while managing downside risk.
According to Seeking Alpha’s coverage, the Touchstone Mid Cap Fund’s performance and positioning underscore the nuanced balancing act required in active mid-cap management in 2025, particularly under the current political and economic regime. The Fund’s experienced portfolio management team is adjusting holdings to maintain exposure to durable business models and emerging secular growth, aiming to deliver differentiated long-term returns in a volatile market.
Explore more exclusive insights at nextfin.ai.
